Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum -lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae

被引：4
|
作者：
Watkins, Richard R. [1 ,2 ]
Deresinski, Stan [3 ]
机构：
[1] Northeast Ohio Med Univ, Dept Internal Med, Rootstown, OH USA
[2] Cleveland Clin Akron Gen, Div Infect Dis, Akron, OH 44302 USA
[3] Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA
来源：
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2017年 / 15卷 / 10期
关键词：
Antimicrobial resistance; ESBL; beta-lactam/beta-lactamase inhibitors; CRE; blood stream infections; BLOOD-STREAM INFECTIONS; PIPERACILLIN-TAZOBACTAM; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; RISK-FACTORS; BACTEREMIA; PHARMACOKINETICS; MORTALITY; THERAPY; SPREAD;
D O I：
10.1080/14787210.2017.1380519
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：893 / 895
页数：3
相关论文
共 50 条
  • [21] Optimizing therapy of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae
    Gudiol, Carlota
    Cuervo, Guillermo
    Carratala, Jordi
    CURRENT OPINION IN CRITICAL CARE, 2019, 25 (05) : 438 - 448
  • [22] In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline
    Zhang, Yunliang
    Lin, Xiaoyan
    Bush, Karen
    JOURNAL OF ANTIBIOTICS, 2016, 69 (08): : 600 - 604
  • [23] High burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in Gabon
    Schaumburg, Frieder
    Alabi, Abraham
    Kokou, Cosme
    Grobusch, Martin P.
    Koeck, Robin
    Kaba, Harry
    Becker, Karsten
    Adegnika, Akim A.
    Kremsner, Peter G.
    Peters, Georg
    Mellmann, Alexander
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (09) : 2140 - 2143
  • [24] Prevalence of carbapenem-resistant and extended-spectrum beta-lactamase-producing Enterobacteriaceae in a teaching hospital in Ghana
    Sampah, James
    Owusu-Frimpong, Isaac
    Aboagye, Frank Twum
    Owusu-Ofori, Alex
    PLOS ONE, 2023, 18 (10):
  • [25] In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline
    Yunliang Zhang
    Xiaoyan Lin
    Karen Bush
    The Journal of Antibiotics, 2016, 69 : 600 - 604
  • [26] Rates of Fecal Transmission of Extended-Spectrum β-Lactamase-Producing and Carbapenem-Resistant Enterobacteriaceae Among Patients in Intensive Care Units in Korea
    Kim, Jayoung
    Lee, Ji Young
    Kim, Sang Il
    Song, Wonkeun
    Kim, Jae-Seok
    Jung, Seungwon
    Yu, Jin Kyung
    Park, Kang Gyun
    Park, Yeon-Joon
    ANNALS OF LABORATORY MEDICINE, 2014, 34 (01) : 20 - 25
  • [27] Infections with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Changing Epidemiology and Drug Treatment Choices
    Pitout, Johann D. D.
    DRUGS, 2010, 70 (03) : 313 - 333
  • [28] Which non-carbapenem antibiotics are active against extended-spectrum β-lactamase-producing Enterobacteriaceae?
    Bouxom, Helene
    Fournier, Damien
    Bouiller, Kevin
    Hocquet, Didier
    Bertrand, Xavier
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 52 (01) : 100 - 103
  • [29] In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE)
    Zhang, Yunliang
    Kashikar, Ankita
    Bush, Karen
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (10) : 2792 - 2795
  • [30] Extended-Spectrum β-Lactamase-producing Enterobacteriaceae among Travelers from the Netherlands
    Paltansing, Sunita
    Vlot, Jessica A.
    Kraakman, Margriet E. M.
    Mesman, Romy
    Bruijning, Marguerite L.
    Bernards, Alexandra T.
    Visser, Leo G.
    Veldkamp, Karin Ellen
    EMERGING INFECTIOUS DISEASES, 2013, 19 (08) : 1206 - 1213
12345